More articles from Idiopathic interstitial pneumonias

Survival in interstitial lung diseases – 11 years observation of 2497 patients.
Magdalena Martusewicz-Boros, Piotr Boros

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5168; DOI: 10.1183/13993003.congress-2023.PA5168
Idiopathic pulmonary fibrosis mortality among ever-employed persons aged ≥15 years, by industry and occupation—United States, 2021
Jacek Mazurek, Girija Syamlal, David Weissman

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5169; DOI: 10.1183/13993003.congress-2023.PA5169
Sulforaphane (SFN) derivatives attenuate at pulmonary fibrosis both in vivo bleomycin (BLM)-induced model and in vitro TGF-β1-induced model
Sung Hwan Jeong, Eun Suk Son, Sun Young Kyung, Jeong-Woong Park, So Young Park, Young Eun Lee, Se-Hee Kim

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5165; DOI: 10.1183/13993003.congress-2023.PA5165
Leveraging disease progression modeling to aid clinical decision and optimize drug development for Idiopathic Pulmonary Fibrosis (IPF)
Tu Mai, Justin Wilkins, Shweta Vadhavkar, Katerina Samara, Nikhil Kamath, Lin Pan, Joy Hsu

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5164; DOI: 10.1183/13993003.congress-2023.PA5164
Virtual pulmonary rehabilitation for people with idiopathic pulmonary fibrosis: a mixed methods feasibility study
Orlagh O'Shea, Grainne Murphy, Luke Forde, Katherine O'Reilly

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5153; DOI: 10.1183/13993003.congress-2023.PA5153
The prognostic value of blood eosinophils、monocyte count and Neutrophils/Lymphocyte ratio (NLR) in patients with IPF, CPFE and COPD：A retrospective multicenter cohort study
Yen-Fu Chen, Pei-Fen Wu, Hsin-Yi Wang, Chung-Yu Chen, You-Yi Chen, Chia-Ling Chang, Jerry Shu-Hung Kuo, Kuan-Ming Su, Ning Chien, Ping-Hung Kuo, Hao-Chien Wang, Chong-Jen Yu

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5163; DOI: 10.1183/13993003.congress-2023.PA5163
Association between smoking and prognosis in patients with idiopathic pulmonary fibrosis
Min Jee Kim, Hee-Young Yoon, Hoseob Kim, Yoonjong Bae, Jin Woo Song

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5156; DOI: 10.1183/13993003.congress-2023.PA5156
Occurrence of Pneumothorax in patients with pulmonary idiopathic fibrosis and acute respiratory failure treated with High-Flow Nasal Cannula: A Case Series
Chiara Di Maria, Simone Prestifilippo, Claudia Crimi, Carlo Vancheri

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5172; DOI: 10.1183/13993003.congress-2023.PA5172
FVC and DLCO evolution after initiation of antifibrotics as prognostic factors in IPF
Marie Vermant, Tinne Goos, Nathalie Veyt, Stefan Gogaert, Marianne S Carlon, Nico De Crem, Laurens J De Sadeleer, Ellen De Langhe, Adriana Dubbeldam, Bart Vanaudenaerde, Erik K Verbeken, Johny Verschakelen, Birgit Weynand, Jonas Yserbyt, Patrick Verschueren, Joseph Jacob, Wim A Wuyts

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5159; DOI: 10.1183/13993003.congress-2023.PA5159
Second-line antifibrotics in patients with idiopathic pulmonary fibrosis: a real-life experience
Stefano Levra, Giuseppe Guida, Vitina Carriero, Francesca Bertolini, Elisa Arrigo, Elisa Riccardi, Flavio Crosa, Paolo Carlo Ghio, Carlo Albera, Fabio Luigi Massimo Ricciardolo

European Respiratory Journal Sep 2023, 62 (suppl 67) PA5160; DOI: 10.1183/13993003.congress-2023.PA5160

Main menu

User menu

Search

More articles from Idiopathic interstitial pneumonias

Pages

Contact us